Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc Immune Recovery Study (MIRS)
2008-003635-20Phase 4Active
- Sponsor
- University Medical Center Utrecht
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in human immunodeficiency virus infection (HIV) and Human immunodeficiency virus infection type 1 comparing maraviroc with placebo (2 arms). Primary endpoint: Immune recovery measured by CD4+ T-cell increase. Started Jul 2008; status: active.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2008-003635-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003635-20.